Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,863.14
    -13.91 (-0.18%)
     
  • Bitcoin USD

    63,961.44
    +294.89 (+0.46%)
     
  • CMC Crypto 200

    1,376.41
    +63.78 (+5.11%)
     
  • S&P 500

    5,000.79
    -10.33 (-0.21%)
     
  • Dow

    37,958.70
    +183.32 (+0.49%)
     
  • Nasdaq

    15,465.49
    -136.01 (-0.87%)
     
  • Gold

    2,405.90
    +7.90 (+0.33%)
     
  • Crude Oil

    83.00
    +0.27 (+0.33%)
     
  • 10-Yr Bond

    4.6230
    -0.0240 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Why Singapore’s medical tourism threats don’t hurt Raffles Medical

It banks on foreign patients searching for critical care.

Despite looming threats from medical tourism on Singapore’s private healthcare, Raffles Medical Group (RMG) has not yet felt any impact, thanks to a diversified international patients mix.

OCBC revealed that RMG has been receiving lower volume of patients from countries like Indonesia, but this has been offset by an influx of patients from China and Indochina.

“These patients continue to seek critical care, which ensures revenue intensity to an extent,” OCBC said.

On top of this, Singapore remains as an attractive medical hub, “quickly catching up” to the United States, the largest hub for medical tourism, according to a report by Visa and Oxford Economics.

ADVERTISEMENT



More From Singapore Business Review